{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T07:34:09Z","timestamp":1794123249566,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopha.2026.119244","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:21:22Z","timestamp":1773930082000},"page":"119244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["JAK2 inhibition with baricitinib stunts growth and postnatal development in juvenile rats"],"prefix":"10.1016","volume":"198","author":[{"given":"Natalie K.","family":"Gilmore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0467-9298","authenticated-orcid":false,"given":"Alec M.","family":"Avey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Cyun","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9299-3945","authenticated-orcid":false,"given":"Nandhini","family":"Senthil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine A.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9337-6186","authenticated-orcid":false,"given":"Keith","family":"Baar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119244_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/08977194.2012.660936","article-title":"Biology and significance of the JAK\/STAT signalling pathways","volume":"30","author":"Kiu","year":"2012","journal-title":"Growth Factors"},{"key":"10.1016\/j.biopha.2026.119244_bib2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2026.119244_bib3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","article-title":"A Comprehensive overview of globally approved JAK inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119244_bib4","unstructured":"Olumiant\u00ae. \u3008https:\/\/olumiant.lilly.com\u3009."},{"key":"10.1016\/j.biopha.2026.119244_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40265-017-0723-3","article-title":"Baricitinib: first global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2026.119244_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/ph12010037","article-title":"Baricitinib: a 2018 novel FDA-approved small molecule inhibiting janus kinases","volume":"12","author":"Mayence","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2026.119244_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-023-01873-w","article-title":"Baricitinib for the treatment of alopecia areata","volume":"83","author":"Freitas","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2026.119244_bib8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.biopha.2026.119244_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/bjd\/ljad096","volume":"189","author":"Torrelo","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2026.119244_bib10","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1113\/JP284393","article-title":"The rat Achilles and patellar tendons have similar increases in mechanical properties but become transcriptionally divergent during postnatal development","volume":"601","author":"Steffen","year":"2023","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2026.119244_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.matbio.2023.12.007","article-title":"Inhibiting JAK1, not NF-\u03baB, reverses the effect of pro-inflammatory cytokines on engineered human ligament function","volume":"125","author":"Avey","year":"2024","journal-title":"Matrix Biol."},{"key":"10.1016\/j.biopha.2026.119244_bib12","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.0902819","article-title":"Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050","volume":"184","author":"Fridman","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119244_bib13","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.0902819","article-title":"Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050","volume":"184","author":"Fridman","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119244_bib14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jbmr.2539","article-title":"Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones","volume":"30","author":"Jepsen","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2026.119244_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0003-9861(61)90291-0","article-title":"The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid","volume":"93","author":"Woessner","year":"1961","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2026.119244_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0021-9258(19)51149-8","article-title":"The determination of hydroxyproline","volume":"184","author":"Neuman","year":"1950","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119244_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119244_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tem.2017.11.001","article-title":"JAK\/STAT \u2013 emerging players in metabolism","volume":"29","author":"Dodington","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2026.119244_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2018.00035","article-title":"The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects","volume":"9","author":"Dehkhoda","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119244_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2011.06100.x","article-title":"Growth hormone\u2013STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism","author":"Baik","year":"2011","journal-title":"Ann. N. Y. Acad. Sci. 1229"},{"key":"10.1016\/j.biopha.2026.119244_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.reprotox.2022.08.002","article-title":"Lack of direct bone effect of tofacitinib, a JAK inhibitor, in juvenile rats and evaluation of the association between offspring growth and femur length","volume":"113","author":"Campion","year":"2022","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.biopha.2026.119244_bib22","article-title":"Pediatric JAK inhibitor use and height in common inflammatory diseases","author":"Cole","year":"2025","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.biopha.2026.119244_bib23","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jbmr.359","article-title":"IGF-1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP\/Ihh pathway","volume":"26","author":"Wang","year":"2011","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.biopha.2026.119244_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3349\/ymj.2012.53.3.618","article-title":"Altered cellular kinetics in growth plate according to alterations in weight bearing","volume":"53","author":"Park","year":"2012","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.biopha.2026.119244_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay4447","article-title":"JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function","volume":"12","author":"Adam","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119244_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/gerona\/61.6.562","article-title":"Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics","volume":"61","author":"Bonkowski","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.biopha.2026.119244_bib27","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1210\/en.2016-1649","article-title":"Disruption of the GH receptor gene in adult mice increases maximal lifespan in females","volume":"157","author":"Junnila","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopha.2026.119244_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13506","article-title":"Growth hormone receptor gene disruption in mature-adult mice improves male insulin sensitivity and extends female lifespan","volume":"20","author":"Duran-Ortiz","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.biopha.2026.119244_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(23)00921-2","article-title":"Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial","volume":"402","author":"Ramanan","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119244_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12969-023-00817-8","article-title":"Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS\/CANDLE, SAVI, and AGS)","volume":"21","author":"Kanazawa","year":"2023","journal-title":"Pedia Rheuma"},{"key":"10.1016\/j.biopha.2026.119244_bib31","first-page":"1052","article-title":"Growth failure due to JAK inhibition overcome by recombinant IGF-I","volume":"7","author":"Hutchison","year":"2022","journal-title":"J. Pediatr. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119244_bib32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/10428194.2018.1509315","article-title":"Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis","volume":"60","author":"Menghrajani","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.biopha.2026.119244_bib33","first-page":"7","article-title":"Functional hyposplenism","volume":"18","author":"Kirkineska","year":"2014","journal-title":"Hippokratia"},{"key":"10.1016\/j.biopha.2026.119244_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0609.2007.00818.x","article-title":"Erythropoietin after a century of research: younger than ever","volume":"78","author":"Jelkmann","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.biopha.2026.119244_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119244_bib36","doi-asserted-by":"crossref","first-page":"29301","DOI":"10.1074\/jbc.M115.670331","article-title":"Role of Janus kinase 3 in predisposition to obesity-associated metabolic syndrome","volume":"290","author":"Mishra","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119244_bib37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.cmet.2012.11.005","article-title":"Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity","volume":"16","author":"Derecka","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2026.119244_bib38","doi-asserted-by":"crossref","first-page":"22617","DOI":"10.1073\/pnas.1009152108","article-title":"IL-4\/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity","volume":"107","author":"Ricardo-Gonzalez","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2026.119244_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13098-025-01582-2","article-title":"JAK inhibitors: a new choice for diabetes mellitus?","volume":"17","author":"Zhou","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.biopha.2026.119244_bib40","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.2337\/db12-1275","article-title":"STAT4 deficiency reduces obesity-induced insulin resistance and adipose tissue inflammation","volume":"62","author":"Dobrian","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2026.119244_bib41","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2337\/diabetes.55.04.06.db05-1265","article-title":"Opposite effect of JAK2 on insulin-dependent activation of mitogen-activated protein kinases and akt in muscle cells","volume":"55","author":"Thirone","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2026.119244_bib42","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.3390\/ijms21239004","article-title":"JAK\/STAT activation: a general mechanism for bone development, homeostasis, and regeneration","volume":"21","author":"Damerau","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2026.119244_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/ENDO:19:3:249","article-title":"A model for tissue-specific inducible insulin-like growth factor-i (igf-i) inactivation to determine the physiological role of liver-derived IGF-I","volume":"19","author":"Sj\u00f6gren","year":"2002","journal-title":"ENDO"},{"key":"10.1016\/j.biopha.2026.119244_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1084\/jem.20130538","article-title":"Bone resorption is regulated by cell-autonomous negative feedback loop of Stat5\u2013Dusp axis in the osteoclast","volume":"211","author":"Hirose","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119244_bib45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fphys.2019.00500","article-title":"The JAK\/STAT pathway in skeletal muscle pathophysiology","volume":"10","author":"Moresi","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2026.119244_bib46","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-10-0818","article-title":"GH and IGF1 levels are positively associated with musculotendinous collagen expression: experiments in acromegalic and GH deficiency patients","volume":"163","author":"Doessing","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119244_bib47","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1152\/japplphysiol.00593.2022","article-title":"Rapamycin insensitive regulation of engineered ligament structure and function by IGF-1","volume":"135","author":"El Essawy","year":"2023","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.biopha.2026.119244_bib48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0838.2010.01265.x","article-title":"The role of pro-inflammatory and immunoregulatory cytokines in tendon healing and rupture: new insights","volume":"21","author":"Schulze-Tanzil","year":"2011","journal-title":"Scand. Med. Sci. Sports"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:19:34Z","timestamp":1779509974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226002775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"alternative-id":["S0753332226002775"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119244","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAK2 inhibition with baricitinib stunts growth and postnatal development in juvenile rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119244"}}